A synthetic tetrapeptide derived from work on pineal extract (epithalamin) conducted in the Soviet Union and Russia. The claimed mechanism is induction of telomerase activity and consequent telomere maintenance. This mechanism is not independently validated, and the leap from a tetrapeptide to telomerase regulation is not mechanistically explained in the available literature.
The evidence base is the problem. Reports of lifespan extension and telomerase effects originate almost exclusively from a single research lineage, largely published outside mainstream peer review, and have not been independently replicated. Human data are sparse and methodologically weak. This is a peptide where marketing claims dramatically outrun the science.
Not FDA-approved. No approved product in any major jurisdiction.
No meaningful safety data. Note that a compound genuinely capable of inducing telomerase would warrant serious oncological scrutiny — telomerase reactivation is a hallmark of malignancy. The absence of that scrutiny reflects the weakness of the evidence, not the safety of the compound.
Forge Bioenergy does not publish dosing, reconstitution, or administration protocols for any peptide. See our editorial policy for why. If you are considering any substance on this page, that conversation belongs with a licensed physician.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.